on 21 Sep 2021
Last Applicant/ Owned by
SUITE GT-101
DOVER
DE
19901
Serial Number
90356449 filed on 03rd Dec 2020
Registration Number
6490579 registered on 21st Sep 2021
Correspondent Address
Devon E. White
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
research and development in the field of artificial intelligence software for managing, accessing and sharing information and data in the fields of performance metrics, data visualizations, and predictive analytics in the healthcare and life sciences industries; scientific advisory services in the nature of computer modeling services, namely, computer simulation from computer programs for conducti Read More
research and development in the field of artificial intelligence software for managing, accessing and sharing information and data in the fields of performance metrics, data visualizations, and predictive analytics in the healthcare and life sciences industries; scientific advisory services in the nature of computer modeling services, namely, computer simulation from computer programs for conducting mathematical and statistical modeling and simulation of drug effects for third party pharmaceuticals, diagnostic, and health care products; design and development of computer software for use in pharmaceutical research and development; scientific research, namely, research and analysis services in the scientific fields of artificial intelligence and machine learning analytics; research and analysis services in the fields of biology, biotechnology, bioinformatics and in the pharmaceutical field; scientific research, namely, providing data analytics and data modelling to others in the fields of medical and pharmaceutical research and development; providing temporary use of web-based software featuring predictive analytics in the healthcare and life sciences industries; providing temporary use of web-based software for managing, accessing, analyzing, and sharing information and data in the healthcare and life sciences industries, namely, information and data in the fields of real world evidence
15th Jul 2017
19th Jun 2019
providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences
15th Jul 2017
19th Jun 2019
downloadable computer software that uses artificial intelligence for managing, accessing and sharing information and data in the fields of performance metrics, data visualizations, and predictive analytics in the healthcare and life sciences industries; downloadable computer software that uses artificial intelligence for conducting mathematical and statistical modeling and simulation of drug effects for third party pharmaceuticals, diagnostic, and health care products; software featuring machine learning and artificial intelligence for data analysis in the fields of data processing, analytics, information processing, data analysis, artificial intelligence, machine learning, deep learning, compound property prediction, compound structure prediction and data visualization in the fields of chemistry, pharmaceutical and agrochemical research and development; downloadable computer software for use in the pharmaceutical industry for drug discovery and design, clinical trial design, and data analysis for guiding experiment and study related decisions, namely, dose selection, patient selection, risk factor identification, endpoint selection, and for identifying genomic markers for efficacy and safety in support of regulatory submission to support product registration; downloadable computer artificial intelligence software for use in the pharmaceutical industry for drug discovery and design, clinical trial design, and data analysis; downloadable computer software for use in biological and chemical research, development, validation and testing in the life sciences field, including primarily the fields of biology, genomics, proteomics and pharmaceuticals for characterizing mechanism of action, understanding systems level biology and pharmacology, guide dose selection, and identify predictors for efficacy and safety; downloadable software platform using machine learning and artificial intelligence for training deep learning models on medical data and for use in medical predictions for use by healthcare organizations, life science and pharmaceutical companies to enhance precision in care quality, improve patient experience and advance new drugs and treatment methods, namely, building translational models, identifying patterns unknown to biology, augmenting systems biology models, enabling quality-by-design for pharmaceutical manufacturing, guiding treatment trajectory, precision dosing, individualized therapy, and extraction of signal from imaging data; downloadable bioinformatics software for use in healthcare information management and analysis, namely, for capturing, storing, aggregating, viewing, and analyzing medical data, medical test results, diagnostic data, slides and specimens, in the fields of healthcare, medical research and clinical research; downloadable software for use in healthcare information management and analysis, namely, for capturing, storing, aggregating, viewing, and analyzing medical data, medical test results, diagnostic data, slides and specimens, in the fields of healthcare, medical research and clinical research; downloadable medical data monitoring, and applications that record, monitor, and analyze medical data, patient data, and provide patient diagnosis risk assessment for identifying trends related to patient treatment
15th Jul 2017
19th Jun 2019
No 90356449
No Service Mark
No 031536.008
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
16th Oct 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
10th Oct 2024 | TEAS SECTION 7 REQUEST RECEIVED |
21st Sep 2021 | REGISTERED-PRINCIPAL REGISTER |
06th Jul 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
06th Jul 2021 | PUBLISHED FOR OPPOSITION |
06th Jul 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
06th Jul 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
06th Jul 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
16th Jun 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
03rd Jun 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |